BIVI
BioVie Inc
Halal Rating :
Last Price
$2.25
Last updated:
Market Cap
-
7D Change
6.9%
1 Year Change
85.54%
Company Overview
Industries
Exchange
Next Earnings Date
BioVie Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of neurological and inflammatory disorders. The company's primary drug candidates include NE3107 for Alzheimer's Disease and Parkinson's Disease, and BIV201 for treating ascites due to chronic liver cirrhosis.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate BioVie Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.